Dedicated centres and multinational platforms to improve patient care and address early-onset cancers

Nat Rev Cancer. 2024 Nov 11. doi: 10.1038/s41568-024-00777-5. Online ahead of print.

Irit Ben-Aharon^{1

2

3}, Elizabeth Smyth^{4

5}, Anna D Wagner^{4

6}

¹ Division of Oncology, Rambam Health Care Center, Haifa, Israel. i_benaharon@rambam.health.gov.il.
² Technion Integrated Cancer Center, Rappaport Faculty of Medicine, Technion-Israel Institute of Technology, Haifa, Israel. i_benaharon@rambam.health.gov.il.
³ European Organization for Research and Treatment of Cancer (EORTC), Gastrointestinal Tract Cancer Group, Brussels, Belgium. i_benaharon@rambam.health.gov.il.
⁴ European Organization for Research and Treatment of Cancer (EORTC), Gastrointestinal Tract Cancer Group, Brussels, Belgium.
⁵ Oxford NIHR Biomedical Research Centre, Churchill Hospital, Oxford, UK.
⁶ Department of Oncology, Centre Hospitalier Universitaire Vaudois (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.

No abstract available